The burden of critical limb ischemia: a review of recent literature

References

• Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45(Suppl S):S5–S67. doi:10.1016/j.jvs.2006.12.03717223489
   PubMed Web of Science ®Google Scholar
• Gerhard-Herman MD, Gornik HL, Barrett C, et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. J Am Coll Cardiol. 2017;69(11):e71–e126. doi:10.1016/j.jacc.2016.11.00727851992
   PubMed Web of Science ®Google Scholar
• Abu Dabrh AM, Steffen MW, Undavalli C, et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg. 2015;62(6):1642–1651.e1643. doi:10.1016/j.jvs.2015.07.06526391460
   PubMed Web of Science ®Google Scholar
• Alabi O, Roos M, Landry G, Moneta G. Quality-of-life assessment as an outcomes measure in critical limb ischemia. J Vasc Surg. 2017;65(2):571–578. doi:10.1016/j.jvs.2016.08.09727876523
   PubMed Web of Science ®Google Scholar
• Alonso A, Garcia LA. The costs of critical limb ischemia. Endovasc Today. 2011;32–36.
   Google Scholar
• Barshes NR, Belkin M, MOVIE Study Collaborators. Framework for the evaluation of “value” and cost-effectiveness in the management of critical limb ischemia. J Am Coll Surg. 2011;3(4):552–566. doi:10.1016/j.jamcollsurg.2011.07.011
   Google Scholar
• Biancari F. Meta-analysis of the prevalence, incidence and natural history of critical limb ischemia. J Cardiovasc Surg. 2013;54:663–669.24126504
   PubMed Web of Science ®Google Scholar
• Dua A, Lee CJ. Epidemiology of peripheral arterial disease and critical limb ischemia. Tech Vasc Interv Radiol. 2016;19(2):91–95. doi:10.1053/j.tvir.2016.04.00127423989
   PubMedGoogle Scholar
• Farber A, Eberhardt RT. The current state of critical limb ischemia: a systematic review. JAMA Surg. 2016;151(11):1070–1077. doi:10.1001/jamasurg.2016.201827551978
   PubMed Web of Science ®Google Scholar
• Gulati A, Garcia L, Acharji S, et al. Epidemiology of chronic critical limb ischemia In: Dieter RS, editor. Critical Limb Ischemia. Switzerland: Springer International Publishing Switzerland; 2017:9–14.
   Google Scholar
• Lawall H, Zemmrich C, Bramlage P, Aann B. Health related quality of life in patients with critical limb ischemia. Vasa. 2012;41(2):78–88. doi:10.1024/0301-1526/a00016922403125
   PubMed Web of Science ®Google Scholar
• Monaro S, West S, Gullick J. An integrative review of health-related quality of life in patients with critical limb ischaemia. J Clin Nurs. 2016;26:2826–2844. doi:10.1111/jocn.13623
   Web of Science ®Google Scholar
• Shishehbor MH, White CJ, Gray BH, et al. Critical limb ischemia: an expert statement. J Am Coll Cardiol. 2016;68(18):2002–2015. doi:10.1016/j.jacc.2016.04.07127692726
   PubMed Web of Science ®Google Scholar
• Sprengers RW, Teraa M, Moll FL, de Wit GA, van der Graaf Y, Verhaar MC, JUVENTAS Study Group; SMART Study Group. Quality of life in patients with no-option critical limb ischemia underlines the need for new effective treatment. J Vasc Surg. 2010;52(4):843–849. doi:10.1016/j.jvs.2010.04.05720598482
   PubMed Web of Science ®Google Scholar
• Steunenberg SL, Raats JW, Te Slaa A, de Vries J, van der Laan L. Quality of life in patients suffering from critical limb ischemia. Ann Vasc Surg. 2016;36:310–319. doi:10.1016/j.avsg.2016.05.08727427343
   PubMed Web of Science ®Google Scholar
• Uccioli L, Meloni M, Izzo V, Giurato L, Merolla S, Gandini R. Critical limb ischemia: current challenges and future prospects. Vasc Health Risk Manag. 2018;14:63–74. doi:10.2147/VHRM.S12506529731636
   PubMed Web of Science ®Google Scholar
• Nehler MR, Duval S, Diao L, et al. Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population. J Vasc Surg. 2014;60(3):686–695. doi:10.1016/j.jvs.2014.03.29024820900
   PubMed Web of Science ®Google Scholar
• United States Census Bureau, Population Division. Annual Estimates of the Resident Population by Single Year of Age and Sex for the United States: April 1, 2010 to July 1, 2017. Release date June 2018.
   Google Scholar
• Baser O, Verpillat P, Gabriel S, Wang L. Prevalence, incidence, and outcomes of critical limb ischemia in the US Medicare population. Vasc Dis Manag. 2013;10(2):26–36.
   Google Scholar
• Mustapha JA, Katzen BT, Neville RF, et al. Determinants of long-term outcomes and costs in the management of critical limb ischemia: a population-based cohort study. J Am Heart Assoc. 2018;7(16):e009724. doi:10.1161/JAHA.118.00852830369325
   PubMed Web of Science ®Google Scholar
• Centers for Medicare and Medicaid Services; Office of the Actuary. CMS Program Data – populations. July 2018 Version Available from: https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/cms-fast-facts/index.html. Accessed 18, 2019.
   Google Scholar
• Agarwal S, Sud K, Shishehbor MH. Nationwide trends of hospital admission and outcomes among critical limb ischemia patients: from 2003-2011. J Am Coll Cardiol. 2016;67(16):1901–1913. doi:10.1016/j.jacc.2016.02.04027012780
   PubMed Web of Science ®Google Scholar
• Kolte D, Kennedy KF, Shishehbor MH, et al. Thirty-day readmissions after endovascular or surgical therapy for critical limb ischemia: analysis of the 2013 to 2014 Nationwide Readmissions Databases. Circulation. 2017;136(2):167–176. doi:10.1161/CIRCULATIONAHA.117.02762528465288
   PubMed Web of Science ®Google Scholar
• Luders F, Bunzemeier H, Engelbertz C, et al. CKD and acute and long-term outcome of patients with peripheral artery disease and critical limb ischemia. Clin J Am Soc Nephrol. 2016;11(2):216–222. doi:10.2215/CJN.0560051526668023
   PubMed Web of Science ®Google Scholar
• O’Brien-Irr MS, Harris LM, Dosluoglu HH, Dryjski ML. Procedural trends in the treatment of peripheral arterial disease by insurer status in New York State. J Am Coll Surg. 2012;215(3):311–321. doi:10.1016/j.jamcollsurg.2012.05.03322901510
   PubMed Web of Science ®Google Scholar
• Reinecke H, Unrath M, Freisinger E, et al. Peripheral arterial disease and critical limb ischaemia: still poor outcomes and lack of guideline adherence. Eur Heart J. 2015;36(15):932–938. doi:10.1093/eurheartj/ehv00625650396
   PubMed Web of Science ®Google Scholar
• Spreen M, Gremmels H, Teraa M, et al. Decreased limb survival in diabetic patients with critical limb ischemia compared with non-diabetic patients. Cardiovasc Intervent Radiol. 2016;39(3 Supplement 1):S305.
   Google Scholar
• Henry AJ, Hevelone ND, Belkin M, Nguyen LL. Socioeconomic and hospital-related predictors of amputation for critical limb ischemia. J Vasc Surg. 2011;53(2):330–339.e1. doi:10.1016/j.jvs.2010.08.07721163610
   PubMedGoogle Scholar
• Agarwal S, Pitcavage JM, Sud K, Thakkar B. Burden of readmissions among patients with critical limb ischemia. J Am Coll Cardiol. 2017;69(15):1897–1908. doi:10.1016/j.jacc.2017.02.04028279748
   PubMed Web of Science ®Google Scholar
• Malyar NM, Freisinger E, Meyborg M, et al. Low rates of revascularization and high in-hospital mortality in patients with ischemic lower limb amputation: morbidity and mortality of ischemic amputation. Angiology. 2016;67(9):860–869. doi:10.1177/000331971562684926764367
   PubMed Web of Science ®Google Scholar
• Klaphake S, de Leur K, Mulder PGH, et al. Mortality after major amputation in elderly patients with critical limb ischemia. Clin Interv Aging. 2017;12:1985–1992. doi:10.2147/CIA.S13757029200838
   PubMed Web of Science ®Google Scholar
• Freisinger E, Malyar NM, Reinecke H, Lawall H. Impact of diabetes on outcome in critical limb ischemia with tissue loss: a large-scaled routine data analysis. Cardiovasc Diabetol. 2017;16(1):41. doi:10.1186/s12933-017-0624-528376797
   PubMedGoogle Scholar
• Steunenberg SL, de Vries J, Raats JW, et al. Quality of life and mortality after endovascular, surgical, or conservative treatment of elderly patients suffering from critical limb ischemia. Ann Vasc Surg. 2018;51:95–105. doi:10.1016/j.avsg.2018.02.04429772334
   PubMed Web of Science ®Google Scholar
• Steunenberg SL, Te Slaa A, Ho GH, Veen EJ, de Groot HG, van der Laan L. Dementia in patients suffering from critical limb ischemia. Ann Vasc Surg. 2017;38:268–273. doi:10.1016/j.avsg.2016.05.13627575308
   PubMed Web of Science ®Google Scholar
• Pisa G, Reinhold T, Obi-Tabot E, Bodoria M, Brüggenjürgen B. Critical limb ischemia and its impact on patient health preferences and quality of life-an international study. Int J Angiol. 2012;21(3):139–146. doi:10.1055/s-0032-132473823997557
   PubMedGoogle Scholar
• Nordanstig J, Wann-Hansson C, Karlsson J, et al. Vascular Quality of Life Questionnaire-6 facilitates health-related quality of life assessment in peripheral arterial disease. J Vasc Surg. 2014;59(3):700–707. doi:10.1016/j.jvs.2013.08.09924342060
   PubMed Web of Science ®Google Scholar
• Jens S, Conijn AP, Frans FA, et al. Outcomes of infrainguinal revascularizations with endovascular first strategy in critical limb ischemia. Cardiovasc Intervent Radiol. 2015;38(3):552–559. doi:10.1007/s00270-014-0955-525112882
   PubMed Web of Science ®Google Scholar
• Burt RK, Testori A, Oyama Y, et al. Autologous peripheral blood CD133+ cell implantation for limb salvage in patients with critical limb ischemia. Bone Marrow Transplant. 2010;45(1):111–116. doi:10.1038/bmt.2009.10219448678
   PubMed Web of Science ®Google Scholar
• Deutschmann HA, Schoellnast H, Temmel W, et al. Endoluminal therapy in patients with peripheral arterial disease: prospective assessment of quality of life in 190 patients. AJR Am J Roentgenol. 2007;188(1):169–175. doi:10.2214/AJR.05.140817179360
   PubMed Web of Science ®Google Scholar
• Engelhardt M, Bruijnen H, Scharmer C, Wohlgemuth WA, Willy C, Wölfle KD. Prospective 2-years follow-up quality of life study after infrageniculate bypass surgery for limb salvage: lasting improvements only in non-diabetic patients. Eur J Vasc Endovasc Surg. 2008;36(1):63–70. doi:10.1016/j.ejvs.2008.01.02618356087
   PubMed Web of Science ®Google Scholar
• Forbes JF, Adam DJ, Bell J, et al.; BASIL trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: health-related quality of life outcomes, resource utilization, and cost-effectiveness analysis. J Vasc Surg. 2010;51(5Suppl):43S–51S. doi:10.1016/j.jvs.2010.01.07620435261
   PubMedGoogle Scholar
• Keeling AN, Naughton PA, O’Connell A, Lee MJ. Does percutaneous transluminal angioplasty improve quality of life? J Vasc Interv Radiol. 2008;19(2 Pt 1):169–176. doi:10.1016/j.jvir.2007.09.00318341944
   PubMed Web of Science ®Google Scholar
• Kumar BN, Gambhir RP. Critical limb ischemia-need to look beyond limb salvage. Ann Vasc Surg. 2011;25(7):873–877. doi:10.1016/j.avsg.2011.05.02021831588
   PubMed Web of Science ®Google Scholar
• Landry GJ, Esmonde NO, Lewis JR, et al. Objective measurement of lower extremity function and quality of life after surgical revascularization for critical lower extremity ischemia. J Vasc Surg. 2014;60(1):136–142. doi:10.1016/j.jvs.2014.01.06724613190
   PubMed Web of Science ®Google Scholar
• Peeters Weem SM, Teraa M, Den Ruijter HM, de Borst GJ, Verhaar MC, Moll FL. Quality of life after treatment with autologous bone marrow derived cells in no option severe limb ischemia. Eur J Vasc Endovasc Surg. 2016;51(1):83–89. doi:10.1016/j.ejvs.2015.09.01026511056
   PubMed Web of Science ®Google Scholar
• Shigematsu H, Yasuda K, Iwai T, et al. Randomized, double-blind, placebo-controlled clinical trial of hepatocyte growth factor plasmid for critical limb ischemia. Gene Ther. 2010;17(9):1152–1161. doi:10.1038/gt.2010.5120393508
   PubMed Web of Science ®Google Scholar
• van Hattum ES, Tangelder MJ, Lawson JA, Moll FL, Algra A. The quality of life in patients after peripheral bypass surgery deteriorates at long-term follow-up. J Vasc Surg. 2011;53(3):643–650. doi:10.1016/j.jvs.2010.09.02121146344
   PubMed Web of Science ®Google Scholar
• Wohlgemuth WA, Safonova O, Engelhardt M, Freitag M, Wölfle K, Kirchhof K. Improvement of the quality of life concerning the health of patients with peripheral arterial disease (PAD) after successful bypass surgery. Vasa. 2008;37(4):338–344. doi:10.1024/0301-1526.37.4.33819003744
   PubMedGoogle Scholar
• Maglinte GA, Hays RD, Kaplan RM. US general population norms for telephone administration of the SF-36v2. J Clin Epidemiol. 2012;65(5):497–502. doi:10.1016/j.jclinepi.2011.09.00822269331
   PubMed Web of Science ®Google Scholar
• Bague N, Julia P, Sauguet A, et al. Femoropopliteal in-stent restenosis repair: midterm outcomes after paclitaxel eluting balloon use (PLAISIR Trial). Eur J Vasc Endovasc Surg. 2017;53(1):106–113. doi:10.1016/j.ejvs.2016.10.00227890526
   PubMed Web of Science ®Google Scholar
• Brothers TE. Failure of patients with peripheral arterial disease to accept the recommended treatment results in worse outcomes. Ann Vasc Surg. 2015;29(2):244–259. doi:10.1016/j.avsg.2014.08.00625305420
   PubMed Web of Science ®Google Scholar
• Egberg L, Mattiasson AC, Ljungström KG, Styrud J. Health-related quality of life in patients with peripheral arterial disease undergoing percutaneous transluminal angioplasty: a prospective one-year follow-up. J Vasc Nurs. 2010;28(2):72–77. doi:10.1016/j.jvn.2010.02.00120494298
   PubMedGoogle Scholar
• Klepanec A, Mistrik M, Altaner C, et al. No difference in intra-arterial and intramuscular delivery of autologous bone marrow cells in patients with advanced critical limb ischemia. Cell Transplant. 2012;21(9):1909–1918. doi:10.3727/096368912X63694822472173
   PubMed Web of Science ®Google Scholar
• Szende A, Janssen B, Cabases J, editors. Self-Reported Population Health: An International Perspective Based on EQ-5D. EuroQol Group. London, UK: Springer Open; 2014.
   Google Scholar
• Hawthorne G, Herrman H, Murphy B. Interpreting the WHOQOL-BREF: preliminary population norms and effect sizes. Soc Indic Res. 2006;77(1):37–59. doi:10.1007/s11205-005-5552-1
   Web of Science ®Google Scholar
• Corriere MA, Goldman MP, Barnard R, et al. Cumulative number of treatment interventions predicts health-related quality of life in patients with critical limb ischemia. Ann Vasc Surg. 2017;44:41–47.
   Web of Science ®Google Scholar
• Frans FA, Met R, Koelemay MJ, et al. Changes in functional status after treatment of critical limb ischemia. J Vasc Surg. 2013;58(4):957–965.e1. doi:10.1016/j.jvs.2013.04.03424075105
   PubMed Web of Science ®Google Scholar
• Frans FA, Nieuwkerk PT, Met R, et al. Statistical or clinical improvement? Determining the minimally important difference for the vascular quality of life questionnaire in patients with critical limb ischemia. Eur J Vasc Endovasc Surg. 2014;47(2):180–186. doi:10.1016/j.ejvs.2013.10.01224290252
   PubMed Web of Science ®Google Scholar
• Murphy MP, Lawson JH, Rapp BM, et al. Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia. J Vasc Surg. 2011;53(6):1565–1574. doi:10.1016/j.jvs.2011.01.07421514773
   PubMedGoogle Scholar
• Nordanstig J, Pettersson M, Morgan M, Falkenberg M, Kumlien C. Assessment of minimum important difference and substantial clinical benefit with the Vascular Quality of Life Questionnaire-6 when evaluating revascularisation procedures in peripheral arterial disease. Eur J Vasc Endovasc Surg. 2017;54(3):340–347. doi:10.1016/j.ejvs.2017.06.02228754429
   PubMed Web of Science ®Google Scholar
• Sachs T, Pomposelli F, Hamdan A, Wyers M, Schermerhorn M. Trends in the national outcomes and costs for claudication and limb threatening ischemia: angioplasty vs bypass graft. J Vasc Surg. 2011;54(4):1021–1031. doi:10.1016/j.jvs.2011.03.28121880457
   PubMed Web of Science ®Google Scholar
• Malyar N, Fürstenberg T, Wellmann J, et al. Recent trends in morbidity and in-hospital outcomes of in-patients with peripheral arterial disease: a nationwide population-based analysis. Eur Heart J. 2013;34(34):2706–2714. doi:10.1093/eurheartj/eht28823864133
   PubMed Web of Science ®Google Scholar
• Dua A, Desai SS, Patel B, et al. Preventable complications driving rising costs in management of patients with critical limb ischemia. Ann Vasc Surg. 2016;33:144–148. doi:10.1016/j.avsg.2015.11.02626916348
   PubMed Web of Science ®Google Scholar
• Martinez RA, Shnayder M, Parreco J, et al. Nationally representative readmission factors in patients with claudication and critical limb ischemia. Ann Vasc Surg. 2018;52:96–107. doi:10.1016/j.avsg.2018.03.01129777842
   PubMed Web of Science ®Google Scholar
• Peacock JM, Keo HH, Duval S, et al. The incidence and health economic burden of ischemic amputation in Minnesota, 2005-2008. Prev Chronic Dis. 2011;8(6):A141.22005634
   PubMed Web of Science ®Google Scholar
• Barshes NR, Chambers JD, Cohen J, Belkin M. Model To Optimize Healthcare Value in Ischemic Extremities 1 (MOVIE) Study Collaborators. Cost-effectiveness in the contemporary management of critical limb ischemia with tissue loss. J Vasc Surg. 2012;56(4):1015–1024. doi:10.1016/j.jvs.2012.02.06922854267
   PubMed Web of Science ®Google Scholar
• Armstrong EJ, Ryan MP, Baker ER, Martinsen BJ, Kotlarz H, Gunnarsson C. Risk of major amputation or death among patients with critical limb ischemia initially treated with endovascular intervention, surgical bypass, minor amputation, or conservative management. J Med Econ. 2017;20(11):1148–1154. doi:10.1080/13696998.2017.136196128760065
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global report on diabetes 2016. Availbale from: https://www.who.int/diabetes/global-report/en/. Accessed 115, 2019.
   Google Scholar
• World Health Organization Global Health Observatory data repository. Tobacco use: data by country. Available from: http://apps.who.int/gho/data/node.main.65. Accessed 115, 2019.
   Google Scholar
• Reed GW, Raeisi-Giglou P, Kafa R, Malik U. Hospital readmissions following endovascular therapy for critical limb ischemia: associations with wound healing, major adverse limb events, and mortality. J Am Heart Assoc. 2016;5(5):1–9.
   Web of Science ®Google Scholar
• Jones CE, Richman JS, Chu DI, Gullick AA, Pearce BJ, Morris MS. Readmission rates after lower extremity bypass vary significantly by surgical indication. J Vasc Surg. 2016;64(2):458–464. doi:10.1016/j.jvs.2016.03.42227139788
   PubMed Web of Science ®Google Scholar
• Bodewes TC, Soden PA, Ultee KH, et al. Risk factors for 30-day unplanned readmission following infrainguinal endovascular interventions. J Vasc Surg. 2017;65(2):484–494. doi:10.1016/j.jvs.2016.08.09328126175
   PubMed Web of Science ®Google Scholar
• Masoomi R, Shah Z, Quint C, et al. A nationwide analysis of 30-day readmissions related to critical limb ischemia. Vascular. 2018;26(3):239–249. doi:10.1177/170853811772795528836900
   PubMed Web of Science ®Google Scholar
• Marston WA, Davies SW, Armstrong B, et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg. 2006;44:108–114. doi:10.1016/j.jvs.2006.03.02616828434
   PubMed Web of Science ®Google Scholar
• Howard DP, Banerjee A, Fairhead JF, Hands L, Silver LE, Rothwell PM. Population-based study of incidence, risk factors, outcome, and prognosis of ischemic peripheral arterial events: implications for prevention. Circulation. 2015;132(19):1805–1815. doi:10.1161/CIRCULATIONAHA.115.01642426350058
   PubMed Web of Science ®Google Scholar
• Baubeta Fridh E, Andersson M, Thuresson M, et al. Amputation rates, mortality, and pre-operative comorbidities in patients revascularised for intermittent claudication or critical limb ischaemia: a population based study. Eur J Vasc Endovasc Surg. 2017;54:480–486. doi:10.1016/j.ejvs.2017.07.00528797662
   PubMed Web of Science ®Google Scholar
• Soga Y, Iida O, Takahara M, et al. Two-year life expectancy in patients with critical limb ischemia. JACC Cardiovasc Interv. 2014;7(12):1444–1449. doi:10.1016/j.jcin.2014.06.01825523536
   PubMed Web of Science ®Google Scholar
• Melillo E, Micheletti L, Nuti M, et al. Long-term clinical outcomes in critical limb ischemia—a retrospective study of 181 patients. Eur Rev Med Pharmacol Sci. 2016;20:502–508.26914126
   PubMed Web of Science ®Google Scholar
• van Haelst STW, Koopman C, Den Ruijter HM, et al. Cardiovascular and all-cause mortality in patients with intermittent claudication and critical limb ischaemia. BJS. 2018;105:252–261. doi:10.1002/bjs.10657
   Google Scholar
• Wohlgemuth WA, Olbricht W, Klarmann S, et al. [Disease-specific Questionnaire for Quality of Life in Patients with Peripheral Arterial Occlusive Disease in the Stage of Critical Ischemia (FLeQKI)–methodical development of a specific measuring instrument and psychometric evaluation of its validity and reliability (Part 1)]. Rofo. 2007;179(12):1251–1257. doi:10.1055/s-2007-96351518004695
   PubMedGoogle Scholar